Who
Ryan H. Saadi
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Tevogen.
In numbers
- Trades disclosed
- 13
- Buys
- 1
- Sells
- 1
- Bought
- $2,008
- Sold
- $1.8M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 14 Feb 2024
- Last trade
- 14 Sep 2026
- Last filed
- 16 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Sep 2026filed 16 Sep 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —8,000,000 at $0.00 | filing |
| 14 Sep 2026filed 16 Sep 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —8,000,000 at $0.00 | filing |
| 10 Jul 2026filed 10 Jul 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —1,220,000 at $0.00 | filing |
| 10 Jul 2026filed 10 Jul 2026 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —1,220,000 at $0.00 | filing |
| 18 Dec 2025filed 22 Dec 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code G | —50,000 at $0.00 | filing |
| 11 Dec 2025filed 12 Dec 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code G | —460,000 at $0.00 | filing |
| 15 Aug 2025filed 18 Aug 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code G | —20,000 at $0.00 | filing |
| 27 Jun 2025filed 1 Jul 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —8,000,000 at $0.00 | filing |
| 9 Jun 2025filed 9 Jun 2025 | TVGN TevogenBiotechnology | SEC FORM 4 Sold | $1.8M1,438,206 at $1.23 | filing |
| 5 Jun 2024filed 7 Jun 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Bought | $2,0082,607.32 at $0.77 | filing |
| 14 Feb 2024filed 16 Feb 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —98,901,098 | filing |
| 14 Feb 2024filed 16 Feb 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —19,348,954 at $0.00 | filing |
| 14 Feb 2024filed 16 Feb 2024 | TVGN TevogenBiotechnology | SEC FORM 4 Code A | —193,923 | filing |
News
No headline names them, or the companies they trade most, lately.